Glutamic Acid Market To Reach $19,444 Million by 2030

The glutamic acid market was $ 10,496 million, and will advance at a growth rate of 7% in the coming years to reach about $19,444 million by 2030.

Glutamic acid is used for protein production. The increasing consumption of this kind of acid in the food and beverage sector as a food preservative and enhancer, together with the rising necessity for animal feed because of the augmented consumption of poultry products like chicken, pork, turkeys, beef and geese, along with increasing requirement for aquatic products like fish and shrimp, will drive the industrial growth in the future.

Request for sample pages of this report: https://www.psmarketresearch.com/market-analysis/glutamic-acid-market/report-sample

Food and beverage application is giving out the highest revenue with over 83% share in 2021. This is due to the fact that glutamic acid is extensively used as a taste enhancer. For example, monosodium glutamate, a glutamic acid molecule, is usually used for improving the flavor of canned veggies, broths, carbohydrate-based snacks, salad dressings, processed meat, and dairy goods.

The pharma category will grow the fastest, advancing at a growth rate of over 7%, in the years to come. Beneficial policies of the government and increased private investment will drive the pharma business, which will improve the sales of glutamic acid in the years to come.

Animal feed had a significant market share. Glutamic acid is used in animal feed since it endorses reproduction, animal development, antioxidative response health, and immunologic system. Consumers' increasing understanding of nutritious necessities for animals, in cooperation with the augmented necessity for quality and high feed production, will stimulate the requirement for this acid in animal feed application in the years to come.

North America has a substantial share in the glutamic acid market. The increasing demand for pharma will be the main driver of the consumption of glutamic acid consumption. The region's necessity for pharma products, like dietary supplements, is driven by factors like the increase in the elderly population and the surge in cases of diseases like cardiovascular diseases, chronic respiratory diseases, and cancer. Thus, the rising demand for medicinal items will ease the use of acid.

Browse the full report at:  https://www.psmarketresearch.com/market-analysis/glutamic-acid-market

Europe will grow significantly in the years to come, because of the region's thriving pharma industry, which will benefit from the increasing use of pharma drugs and enhancements, the increasing elderly population, and the increasing health awareness among people. Also, the requirement for the acid will be driven by the considerable presence of pharma manufacturers and their increasing emphasis on generating pioneering pharma items.

The increasing consumption of this acid in the food and beverage industry as a food preservative and enhancer, accompanied by the increasing necessity for animal feed because of the augmented consumption of poultry and aquatic products is helping the demand for the glutamic acid to grow rapidly.

About P&S Intelligence

P&S Intelligence is a market research and consulting firm shaping growth strategies for enterprises with a global as well as niche presence. We specialize in both syndicate and custom market research, creating insight-laden reports that allow customers to stay ahead at every curve. Our clients range from multi-billion-dollar behemoths across industries to up and coming MSMEs and startups. Moreover, with our new offering, government, and public sector advisory services, we continue to trudge ahead in our quest for revolutionizing the way economies shape themselves in these ever-changing times.

Contact:
Chandra Mohan
AVP - Business Development
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Blogs: https://worldwideanalysistrends.blogspot.com/
Follow Us: https://www.linkedin.com/company/pnsintelligence/

This release was published on openPR.